Loading stock data…
$0.59-0.03 (-4.94%)
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
Nuwellis, Inc. in the Healthcare sector is trading at $0.59 with a market capitalization of $2M. The stock is currently near its 52-week low of $0.59, remaining 98.1% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 16 is oversold, raising the odds of a near-term bounce. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.97M↓ | $2.40M↓ | $2.42M↑ | $2.22M↑ | $1.73M |
| Gross Profit | $1.50M↓ | $1.68M↑ | $1.65M↑ | $1.45M↑ | $958,000 |
| Operating Income | -$3.17M↑ | -$4.57M↓ | -$2.44M↑ | -$2.70M↑ | -$2.91M |
| Net Income | -$4.83M↓ | -$4.54M↓ | -$2.42M↓ | $468,000↑ | -$12.55M |
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from...